Zenith Pure Oil published the documents for the Annual General Meeting of Zenith Pure Oil Plc. to be held on 24 April 2014...

Zenith Pure Oil Plc. hereby informs the capital market participants, that it published the documents for the Annual General Meeting to be held on 24th April 2014 based on the result of the circular voting of Board of Directors, closed on 2nd April 2014.

• The Company published the audited parent company and consolidated financial statements as well as the Management Discussion & Analysis for the business year of 2013.
• The Board of Directors recommended paying out HUF 60 bn as a dividend for the financial year ended 31st December 2013. The proposed HUF 60bn is the sum of the current regular and the special dividends, HUF 47bn and HUF 13bn, respectively.
• The Board of Directors recommended the waiver to be granted to the executive officers according to Subsection (5) of Section 30 of the Company Act.
• The Audit Committee of the Company recommended the election of the auditor for the 2014 financial year and determination of its remuneration as well as the material elements of its engagement.
• The Board of Directors recommended granting the authorization to acquire treasury shares.
• The Board of Directors recommended re-electing Dr. Sándor Csányi as a member of the Board of Directors. Taking into account that Mr. Mulham Al-Jarf indicated in writing today his resignation from the Board of Directors with an effective date of 29th April 2014 Board of Directors recommended electing Dr. Anwar al-Kharusi as a member of the Board of Directors. Furthermore, the Board of Directors recommended electing Dr. Anthony Radev as a member of the Board of Directors.
• The Board of Directors recommended the amendment of the Articles of Association including the authorization granted for the Board of Directors to increase the share capital (Article 17) and amendments with respect to the new Civil Code.

The Company will publish its final financial statements after their approval by the Annual General Meeting.

For further information, please contact:

Investor Relations + 36 1 464 1395
facsimile: + 36 1 464 1335